Cumberland Pharmaceuticals (CPIX) vs Journey Medical (DERM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed Journey Medical (DERM) over the past year, gaining 193.5% versus a loss of 55.8%. Over five years, CPIX leads with a +161.9% price change compared with -61.1% for DERM. Journey Medical is the larger company by market cap ($93.2 million vs $87.6 million), about 1.1 times the size, while Cumberland Pharmaceuticals is growing revenue faster (+17.6% vs +10.2%).
Cumberland Pharmaceuticals converts more of its revenue into profit, with a net margin of -6.4% versus -18.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPIX | DERM |
|---|---|---|
| Share price | $5.84 | $3.30 |
| Market cap | $87.57M | $93.16M |
| 1-day change | -7.30% | -7.04% |
| YTD return | +46.73% | -57.20% |
| 1-year return | +193.47% | -55.76% |
| 5-year return | +161.88% | -61.13% |
| Forward P/E | 41.71 | — |
| EPS (TTM) | $-0.57 | $-0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $44.52M | $61.86M |
| Revenue growth (YoY) | +17.57% | +10.20% |
| Net income (latest FY) | $-2.84M | $-11.43M |
| Gross margin | 85.02% | 66.17% |
| Operating margin | -6.27% | -13.21% |
| Net margin | -6.37% | -18.48% |
| 52-week high | $9.28 | $9.56 |
| 52-week low | $2.00 | $3.21 |
| Distance from 52-week high | -37.07% | -65.46% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +286.36% |
| Average volume | 114.52K | 190.39K |
| Shares outstanding | 15.00M | 22.23M |
| Employees | 88 | 58 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CPIX has outperformed DERM by 249.2 percentage points over the past year.
- Cumberland Pharmaceuticals is more profitable, keeping -6.4 cents of every revenue dollar as net income versus -18.5 cents for Journey Medical.
- Cumberland Pharmaceuticals grew revenue faster in its latest fiscal year (+17.57% vs +10.20%).
About Cumberland Pharmaceuticals
CPIX stock →Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.
Health Care · Biotechnology: Pharmaceutical Preparations · 88 employees
About Journey Medical
DERM stock →Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.
Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees
CPIX vs DERM FAQ
Which is bigger, Cumberland Pharmaceuticals or Journey Medical?
Journey Medical (DERM) is larger, with a market capitalization of $93.16M compared with $87.57M for Cumberland Pharmaceuticals (CPIX).
Which stock has performed better over the past year, CPIX or DERM?
CPIX returned +193.47% over the past 12 months, compared with -55.76% for DERM (price return, excluding dividends). Past performance does not predict future results.
Are Cumberland Pharmaceuticals and Journey Medical in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.